ERCP

GI Alliance Partners with Digestive Disease Consultants

Retrieved on: 
Thursday, January 6, 2022
Health, Environment, Patient, Physician, ERCP, Endoscopic retrograde cholangiopancreatography, Gastrointestinal disease, CEO, MD, EUS, GI, Partnership, List of Medknow Publications academic journals, IGG, Consultant, Medicine, Central Illinois

DALLAS, Jan. 6, 2022 /PRNewswire/ -- GI Alliance , the nation's largest independent gastroenterology services organization, is excited to announce its partnership with Digestive Disease Consultants, the leading provider of independent GI services providing quality care to patients in the Normal and Bloomington areas of Illinois.

Key Points: 
  • DALLAS, Jan. 6, 2022 /PRNewswire/ -- GI Alliance , the nation's largest independent gastroenterology services organization, is excited to announce its partnership with Digestive Disease Consultants, the leading provider of independent GI services providing quality care to patients in the Normal and Bloomington areas of Illinois.
  • This expansion complements GI Alliance's presence as the leading provider of independent GI care in the state and the Midwest.
  • Partnering with GI Alliance allows us to take advantage of the strong foundation established in Illinois.
  • "The physicians and staff at Digestive Disease Consultants are a terrific addition to our Midwest region practices," said Jim Weber, M.D., CEO of GI Alliance.

New Book by Capital Health Cancer Specialists Looks at Cutting-Edge Care Options

Retrieved on: 
Monday, January 3, 2022
Capital Health, Diagnosis, ERCP, Gastroenterology, Cancer, Springer, Treatment, HPB, EMR, Multimedia, Century, Endoscopic mucosal resection, Health, Incidence, Therapeutic endoscopy, Patient, Endoscopy, Research, Pancreas, Liver, View, EUS, Medical imaging

"Patients with hepato-pancreato-biliary malignancies face enormous challenges that require a multidisciplinary team of providers to manage their care from diagnosis through treatment," said Dr. Cataldo Doria.

Key Points: 
  • "Patients with hepato-pancreato-biliary malignancies face enormous challenges that require a multidisciplinary team of providers to manage their care from diagnosis through treatment," said Dr. Cataldo Doria.
  • As medical director of the Capital Health Cancer Center, Dr. Doria oversees clinical operations including disease-specific clinical performance groups, clinical research, and cancer care advancements to ensure widespread access to the best possible patient care and outcomes.
  • Capital Health Cancer Center, located at Capital Health Medical Center - Hopewell, is the area's most advanced provider of cancer treatment delivered by some of the most experienced medical experts.
  • For more information about Capital Health Cancer Center, visit capitalhealth.org/cancer .

Vanguard Gastroenterology in Manhattan Emphasizes Importance of Colon Cancer Screenings Given Findings of Increased Early-onset Colon Cancer Rates Reported in JAMA

Retrieved on: 
Friday, December 3, 2021
Patient, Man, News, University of Colorado School of Medicine, Signs and symptoms, Time, American Gastroenterological Association, Woman, MD, JAMA Network Open, Cancer, University, Program, Weight loss, History, Abdominal pain, Inflammatory bowel disease, ACG, ERCP, Medicine, Anemia, Pain, Risk, AGA, Capsule endoscopy, American Society for Gastrointestinal Endoscopy, American College, Society, ASGE, United, Transplant, Gastrointestinal Endoscopy, American College of Gastroenterology, Disease, CRC, COVID, Pharmaceutical industry, Medical imaging

NEW YORK, Dec. 3, 2021 /PRNewswire-PRWeb/ -- Vanguard Gastroenterology of Manhattan ( http://www.gastro-nyc.com ) is helping raise the alarm over additional news of increased early-onset colon cancer rates.

Key Points: 
  • NEW YORK, Dec. 3, 2021 /PRNewswire-PRWeb/ -- Vanguard Gastroenterology of Manhattan ( http://www.gastro-nyc.com ) is helping raise the alarm over additional news of increased early-onset colon cancer rates.
  • As reported in JAMA Network Open in November, a cross-sectional study by the University of Colorado School of Medicine revealed that rates of early-onset colorectal adenocarcinoma have increased.
  • These findings follow the United StatesMulti-Society Task Force(MSTF) onColorectal Cancerupdated screening recommendations, endorsing 45 instead of 50 as the age to start average-risk CRC screenings.
  • "Fortunately, colon cancer is preventable, with timely colonoscopy screening able to detect and remove pre-cancerous growth and prevent colon cancer," added Vanguard Gastroenterology colleague Inessa Khaykis, MD.

Global Pancreatic and Biliary Stent (General Surgery) Market Analysis and Forecast Model with Impact of COVID-19 - ResearchAndMarkets.com

Retrieved on: 
Friday, November 26, 2021
Surgery, Health, Market access, General surgery, Review, Forecast model, General officer, Pancreatitis, Commonwealth Associates, Inc., Industry, Bile, SWOT, Gallbladder, Boston Scientific, COVID-19, Epidemiology, Obstruction, ERCP, Investment, C. R. Bard, Stent, Percutaneous transhepatic cholangiography, Jaundice, Pancreatic duct, PTC, Internet, Medtronic, Pancreas, Pharmaceutical industry, Medical imaging, Retail, Marketing

The "Pancreatic and Biliary stent (General Surgery) - Global Market Analysis and Forecast Model (COVID-19 Market Impact)" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Pancreatic and Biliary stent (General Surgery) - Global Market Analysis and Forecast Model (COVID-19 Market Impact)" report has been added to ResearchAndMarkets.com's offering.
  • The model discusses in detail the impact of COVID-19 on Pancreatic and Biliary Stents market for the year 2020 and beyond.
  • The Pancreatic and biliary stents market is mainly driven by the diseases resulting in the obstruction in bile or pancreatic ducts.
  • Track device sales in the global and country-specific Pancreatic and Biliary Stents market from 2015-2030.

Ohio Physician Becomes the First Doctor in the U.S. to Use Ambu’s Single-Use Duodenoscope in 100 Procedures

Retrieved on: 
Thursday, November 4, 2021
Oncology, Medical Devices, Health, FDA, Surgery, General Health, Safety, Memorial Hospital of South Bend, Research, Efficiency, Technology, Diagnosis, LinkedIn, Hospital, Cancer, Neoplasm, Twitter, ERCP, Patient, Marketing, FDA, Food, YouTube, Duodenum, Feedback, Inc., Regulation of food and dietary supplements by the U.S. Food and Drug Administration, Physician, Life, Red Dot, Health, Endoscopy, Asia, GI, Multimedia, Pancreas, Ambu, Bile, Solution, Gallstone, Pancreatitis, Medical device, Pharmaceutical industry

Ambu Inc. , the world leader in single-use endoscopy, announced today that an Ohio gastroenterologist has become the first physician in the U.S. to use Ambus new sterile, single-use duodenoscope in 100 endoscopic retrograde cholangiopancreatography (ERCP) procedures.

Key Points: 
  • Ambu Inc. , the world leader in single-use endoscopy, announced today that an Ohio gastroenterologist has become the first physician in the U.S. to use Ambus new sterile, single-use duodenoscope in 100 endoscopic retrograde cholangiopancreatography (ERCP) procedures.
  • View the full release here: https://www.businesswire.com/news/home/20211104005729/en/
    Ambu recognizes Dr. Juan Tejada (left) for performing 100 procedures with its aScope Duodeno.
  • (Photo: Business Wire)
    Dr. Juan Tejada, a gastroenterologist and advanced endoscopist at Memorial Health System in Marietta, Ohio, recently began using Ambus aScope Duodeno , calling it a win for both physicians and patients.
  • Memorial Health System, which operates hospitals in Marietta, Ohio, and health facilities across southeastern Ohio and northwestern West Virginia, also becomes the first hospital system in the U.S. to adopt Ambus aScope Duodeno.

Global Automated Endoscope Reprocessors (AER) Market Report 2021: Breakthrough Technologies and Strategic Collaborations Drive Growth Strategies - ResearchAndMarkets.com

Retrieved on: 
Tuesday, October 19, 2021
Medical Devices, Health, CSSD, Risk, HLD, Technology, COVID-19, ERCP, Growth, Center, Boston Scientific, AEC Q-type, ASC, Medicaid, Adoption, Hospital, AEC, Endoscopy, Industry, AERS, Workflow, Efficiency, Ambu, Physician, AER, Medicare, Maintenance, Medical device

The "Global Automated Endoscope Reprocessors (AER) Market Growth Opportunities, 2021" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Global Automated Endoscope Reprocessors (AER) Market Growth Opportunities, 2021" report has been added to ResearchAndMarkets.com's offering.
  • While the entire healthcare industry adapts to changes induced by the COVID-19 pandemic, the endoscope reprocessing industry undergoes a major technology transformation.
  • The rise in multiple infection outbreaks from contaminated endoscopes due to faulty endoscope reprocessing and manual errors in cleaning presents huge growth potential for automated endoscope reprocessors (AER), which offer high-level disinfection (HLD) in endoscope reprocessing.
  • AER manufacturers are seeking ways to retain or strengthen their market share in the endoscope reprocessing market.

Maram Zakko is recognized by Continental Who's Who

Retrieved on: 
Tuesday, August 31, 2021
Yale University, Fellow, Continental, College, University, American Board of Commissioners for Foreign Missions, Yale school, ABIM, ERCP, St. Raphael's Hospital, Internal medicine, Multimedia, Yale School of Medicine, University of Connecticut, Arch, Patient, College of Dentistry University of Baghdad, SAN, Faculty, Hospital, American Board of Internal Medicine, Yale New Haven Hospital, View, Medicine

SAN DIEGO, Aug. 31, 2021 /PRNewswire/ -- Maram Zakko is being recognized by Continental Who's Who as a Trusted Gastroenterologist for his exceptional work in the field of Gastroenterology.

Key Points: 
  • SAN DIEGO, Aug. 31, 2021 /PRNewswire/ -- Maram Zakko is being recognized by Continental Who's Who as a Trusted Gastroenterologist for his exceptional work in the field of Gastroenterology.
  • Dr. Zakko has been treating patients since 1998, and is proud to have many loyal patients.
  • To achieve his successful career in medicine, Dr. Zakko attended the College of Medicine at the University of Baghdad.
  • As a specialist of digestive medicine, Dr. Zakko treats patients for a wide range of gastrointestinal issues and digestive issues.

Insights on the Gastrointestinal Endoscopy Devices Global Market to 2027 - Featuring Abbott Nutrition, Cardinal Health and ConMed Among Others - ResearchAndMarkets.com

Retrieved on: 
Friday, August 13, 2021
Medical Devices, Health, CAGR, COVID-19, Growth, ERCP, Pet, Video game

The "Gastrointestinal (GI) Endoscopy Devices - Global Market Trajectory & Analytics" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Gastrointestinal (GI) Endoscopy Devices - Global Market Trajectory & Analytics" report has been added to ResearchAndMarkets.com's offering.
  • Endoscopic Retrograde Cholangiopancreatography Devices (ERCP), one of the segments analyzed in the report, is projected to record a 4.7% CAGR and reach US$21 Billion by the end of the analysis period.
  • The U.S. Market is Estimated at $8.2 Billion, While China is Forecast to Grow at 7.1% CAGR
    The Gastrointestinal (GI) Endoscopy Devices market in the U.S. is estimated at US$8.2 Billion in the year 2020.
  • In the global GI Videoscopes segment, USA, Canada, Japan, China and Europe will drive the 4% CAGR estimated for this segment.